SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-16-015338
Filing Date
2016-05-16
Accepted
2016-05-16 16:12:06
Documents
44
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1601316_10q.htm 10-Q 228510
2 EXHIBIT 31.1 t1601316_ex31-1.htm EX-31.1 8982
3 EXHIBIT 32.1 t1601316_ex32-1.htm EX-32.1 4752
  Complete submission text file 0001571049-16-015338.txt   2275070

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE mrna-20160331.xml EX-101.INS 422721
5 XBRL SCHEMA FILE mrna-20160331.xsd EX-101.SCH 29307
6 XBRL CALCULATION FILE mrna-20160331_cal.xml EX-101.CAL 22840
7 XBRL DEFINITION FILE mrna-20160331_def.xml EX-101.DEF 107534
8 XBRL LABEL FILE mrna-20160331_lab.xml EX-101.LAB 254559
9 XBRL PRESENTATION FILE mrna-20160331_pre.xml EX-101.PRE 183235
Mailing Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 161653882
SIC: 2834 Pharmaceutical Preparations